SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006677
Filing Date
2024-02-14
Accepted
2024-02-14 16:15:42
Documents
15
Period of Report
2024-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40903
2 ex10-1.htm EX-10.1 25988
  Complete submission text file 0001493152-24-006677.txt   247279

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE age-20240209.xsd EX-101.SCH 3009
4 XBRL LABEL FILE age-20240209_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE age-20240209_pre.xml EX-101.PRE 22356
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3737
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 24638424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)